Hemopure Study Set For Committee Review, Firm Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Biopure's oxygen therapeutic Hemopure [hemoglobin glutamer - 250 (bovine)] will be the topic of an FDA advisory committee July 14, the firm says